Literature DB >> 25379631

Focal choroidal excavation associated with focal retinochoroiditis.

Tetsutaro Ohki1, Tsutomu Sakai, Hiroshi Tsuneoka.   

Abstract

PURPOSE: To describe detailed spectral-domain optical coherence tomography (OCT) findings for two patients with focal choroidal excavation (FCE) associated with focal retinochoroiditis. CASE REPORT: Three eyes from two patients with FCE associated with focal retinochoroiditis were evaluated by funduscopy, fluorescence angiography, indocyanine green angiography, and spectral-domain OCT during follow-up. Both patients with focal retinochoroiditis developed new FCE after oral steroid treatment and two eyes showed regression of the FCE during the follow-up. Both eyes from one patient transformed from the conforming to the nonconforming type and neither of the eyes were stable during the follow-up. Ultimately, all eyes exhibited the conforming-type FCE.
CONCLUSIONS: Focal choroidal excavation can be seen as a tomographic phenotype after the treatment of focal retinochoroiditis. Spectral-domain OCT was useful for detecting the development of FCE after the treatment and for observing FCE regression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25379631     DOI: 10.1097/OPX.0000000000000443

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  Morphological changes of focal choroidal excavation.

Authors:  Chen Zheng-Yu; Shao Lei; Wei Wen-Bin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-04       Impact factor: 3.117

2.  Focal choroidal excavation complicated with choroidal neovascularization: a case report and review of the literature.

Authors:  Rui-Lin Zhu; Xiao-Peng Gu; Ya-Di Zhang; Liu Yang
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

3.  Multimodal Imaging Evaluations of Focal Choroidal Excavations in Eyes with Central Serous Chorioretinopathy.

Authors:  Yao Wang; Zhi-Qing Chen; Wei Wang; Xiao-Yun Fang
Journal:  J Ophthalmol       Date:  2016-06-29       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.